
    
      A double-blind, multicenter, randomized, controlled trial (RCT) that will evaluate the
      efficacy of a single dose of Autologous Protein Solution (APS) in patients with
      Osteoarthritis (OA) of the knee who have failed at least 1 conservative OA therapy (e.g.
      physiotherapy, simple analgesics, intra-articular injection).
    
  